News & Articles

Sensor could be used in discovering new treatments for mental illness, in neuroscience research and to detect drugs of abuse

Anti-cancer drug delivery to target tumor sites now becomes more effective with novel multi-stimuli-responsive drug delivery systems

An insider’s view on leveraging the latest single-cell technologies, including cell sorting and single-cell sequencing, to understand what drives response or resistance in checkpoint therapies

Keep up to date with the latest research and discover the tools and techniques advancing 3D cell culture and its applications

Each line of ValuPanel Reagents consists of separately delivered probes and primers, which allow assay flexibility and sizes that can help facilitate scale-up

AI could hold the key to more targeted treatment, according to new research

Dr. David Andrews, AstraZeneca, discusses the future of small-molecule drug discovery for PPIs

Watch world-leading scientists online, May 11-12, to discover the latest tools and techniques advancing COVID-19 research, immunotherapy development, drug screening, cancer diagnostics and more

Reserve your place today for talks on topics ranging from food fraud, spatial infiltration and CRISPR to antibody and AAV gene therapies

Explore topics from food fraud and flow cytometry to pharmaceutical solid-phase microextraction and vaccine, cell & gene therapy production

Discover how a brain organoid core facility is applying its glioblastoma model towards developing patient mini-brains

Potent antibodies shown to retain binding to major COVID-19-causing “South African” variant

The partnership will accelerate clinical validation and commercialization of certain NGS, mass spectrometry and immunology diagnostic tools

Innovative qPCR platform simplifies molecular diagnostic workflows for infectious disease, oncology and COVID-19 testing

The assay has the ability to sequence and surveil evolution of virus mutations over time and geography

This study offers new insights into high grade serous ovarian cancer that have the potential to make an impact in how patients are treated in the future

This partnership aims to offer an accelerated route to market rapid test technologies

Lenco Diagnostic Laboratories among first to offer Beckman Coulter’s semi-quantitative antibody test